IMRIS Release: Zhengzhou Neurosurgeons Perform First iMRI Case in VISIUS® Surgical Theatre
Published: Feb 07, 2013
Brings cutting edge surgery and precise tumor operation platform to patient care
WINNIPEG, Feb. 7, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at the First Affiliated Hospital of Zhengzhou University in Zhengzhou City, China, have successfully performed the first case involving an adult male brain tumor patient using the recently installed VISIUS® Surgical Theatre.
Allowing for multiple MR scanning during brain tumor operations without compromising patient safety, the VISIUS Surgical Theatre features a high-field MR scanner that travels on demand using ceiling-mounted rails into a state-of-the-art neurosurgical operating room. As in this initial case, serial scanning gives the surgeon the ability to assess and perform further resection to remove as much tumor as possible.
With integrated technologies and control systems for imaging, patient-handling and information management, the VISIUS Surgical Theatre provides unmatched intraoperative vision to surgeons to assist in their surgical decision-making and enhance treatment precision. When not needed for intraoperative imaging, the scanner remains in a diagnostic room where it can be used for inpatient and outpatient imaging.
Zhengzhou University Hospital is the third IMRIS system installed in China. Other locations are: PLA General Hospital in Beijing and Huashan Hospital at Fudan University in Shanghai. Two other VISIUS Surgical Theatres are currently being installed at Peking Union Medical College Hospital in Beijing and First Affiliated Hospital of Jilin University in Changchun.
The day before the first procedure, Dr. Xianzhi Liu, chief neurosurgeon, reviewed the surgical suite with province health department representatives. "Since we are the biggest and leading hospital in Henan province," he said, "we have a responsibility to our patients to utilize cutting edge technology that brings the most precise surgical capabilities."
When the hospital announced purchase of the VISIUS Surgical Theatre in March 2012, Kan Quancheng, hospital president, said the suite "is the essential, leading-edge technology that will take us to the next level of research and clinical practice, especially in neurosurgery."
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.